Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1991 Nov 15;145(10):1301–1325.

Report of a National Workshop on Screening for Cancer of the Cervix.

A B Miller 1, G Anderson 1, J Brisson 1, J Laidlaw 1, N Le Pitre 1, P Malcolmson 1, P Mirwaldt 1, G Stuart 1, W Sullivan 1
PMCID: PMC1335946  PMID: 1933712

Full text

PDF
1301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton P. R. American Society for Cytotechnology quality assurance survey data. Summary report. Acta Cytol. 1989 Jul-Aug;33(4):451–454. [PubMed] [Google Scholar]
  2. Berrino F., Gatta G., d'Alto M., Crosignani P., Riboli E. Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. IARC Sci Publ. 1986;(76):111–123. [PubMed] [Google Scholar]
  3. Boyes D. A., Morrison B., Knox E. G., Draper G. J., Miller A. B. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med. 1982;5(1):1–29. [PubMed] [Google Scholar]
  4. Carmichael J. A., Jeffrey J. F., Steele H. D., Ohlke I. D. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol. 1984 Mar 1;148(5):685–690. doi: 10.1016/0002-9378(84)90774-9. [DOI] [PubMed] [Google Scholar]
  5. Carmichael J. A., Maskens P. D. Cervical dysplasia and human papillomavirus. Am J Obstet Gynecol. 1989 Apr;160(4):916–918. doi: 10.1016/0002-9378(89)90310-4. [DOI] [PubMed] [Google Scholar]
  6. Clarke E. A., Anderson T. W. Does screening by "Pap" smears help prevent cervical cancer? A case-control study. Lancet. 1979 Jul 7;2(8132):1–4. doi: 10.1016/s0140-6736(79)90172-7. [DOI] [PubMed] [Google Scholar]
  7. Cohen M. M., Hammarstrand K. M. Papanicolaou test coverage without a cytology registry. Am J Epidemiol. 1989 Feb;129(2):388–394. doi: 10.1093/oxfordjournals.aje.a115142. [DOI] [PubMed] [Google Scholar]
  8. Cook G. A., Draper G. J. Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer. 1984 Sep;50(3):367–375. doi: 10.1038/bjc.1984.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coppleson L. W., Brown B. Observations on a model of the biology of carcinoma of the cervix: a poor fit between observation and theory. Am J Obstet Gynecol. 1975 May 1;122(1):127–136. doi: 10.1016/0002-9378(75)90627-4. [DOI] [PubMed] [Google Scholar]
  10. Cramer D. W. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer. 1974 Dec;34(6):2018–2027. doi: 10.1002/1097-0142(197412)34:6<2018::aid-cncr2820340621>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  11. Eddy D. M. The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data. Cancer. 1987 Sep 1;60(5):1117–1122. doi: 10.1002/1097-0142(19870901)60:5<1117::aid-cncr2820600533>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  12. Fink D. J. Change in American Cancer Society Checkup Guidelines for detection of cervical cancer. CA Cancer J Clin. 1988 Mar-Apr;38(2):127–128. doi: 10.3322/canjclin.38.2.127. [DOI] [PubMed] [Google Scholar]
  13. Hakama M., Chamberlain J., Day N. E., Miller A. B., Prorok P. C. Evaluation of screening programmes for gynaecological cancer. Br J Cancer. 1985 Oct;52(4):669–673. doi: 10.1038/bjc.1985.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kinlen L. J., Spriggs A. I. Women with positive cervical smears but without surgical intervention. A follow-up study. Lancet. 1978 Aug 26;2(8087):463–465. doi: 10.1016/s0140-6736(78)91457-5. [DOI] [PubMed] [Google Scholar]
  15. Kjaer S. K., Engholm G., Teisen C., Haugaard B. J., Lynge E., Christensen R. B., Møller K. A., Jensen H., Poll P., Vestergaard B. F. Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study. Am J Epidemiol. 1990 Apr;131(4):669–682. doi: 10.1093/oxfordjournals.aje.a115551. [DOI] [PubMed] [Google Scholar]
  16. Kjaer S. K., Poll P., Jensen H., Engholm G., Haugaard B. J., Teisen C., Christensen R. B., Möller K. A., Vestergaard B. F., de Villiers E. M. Abnormal Papanicolaou smear. A population-based study of risk factors in Greenlandic and Danish women. Acta Obstet Gynecol Scand. 1990;69(1):79–86. doi: 10.3109/00016349009021044. [DOI] [PubMed] [Google Scholar]
  17. Kjaer S. K., Teisen C., Haugaard B. J., Lynge E., Christensen R. B., Møller K. A., Jensen H., Poll P., Vestergaard B. F., de Villiers E. M. Risk factors for cervical cancer in Greenland and Denmark: a population-based cross-sectional study. Int J Cancer. 1989 Jul 15;44(1):40–47. doi: 10.1002/ijc.2910440108. [DOI] [PubMed] [Google Scholar]
  18. Kjaer S. K., de Villiers E. M., Haugaard B. J., Christensen R. B., Teisen C., Møller K. A., Poll P., Jensen H., Vestergaard B. F., Lynge E. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer. 1988 Apr 15;41(4):518–524. doi: 10.1002/ijc.2910410408. [DOI] [PubMed] [Google Scholar]
  19. Koutsky L. A., Galloway D. A., Holmes K. K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122–163. doi: 10.1093/oxfordjournals.epirev.a036020. [DOI] [PubMed] [Google Scholar]
  20. La Vecchia C., Franceschi S., Decarli A., Fasoli M., Gentile A., Tognoni G. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984 Oct 6;2(8406):779–782. doi: 10.1016/s0140-6736(84)90705-0. [DOI] [PubMed] [Google Scholar]
  21. Lără E., Day N. E., Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987 May 30;1(8544):1247–1249. doi: 10.1016/s0140-6736(87)92695-x. [DOI] [PubMed] [Google Scholar]
  22. Macgregor J. E., Moss S. M., Parkin D. M., Day N. E. A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) 1985 May 25;290(6481):1543–1546. doi: 10.1136/bmj.290.6481.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miller A. B., Lindsay J., Hill G. B. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer. 1976 May 15;17(5):602–612. doi: 10.1002/ijc.2910170508. [DOI] [PubMed] [Google Scholar]
  24. Parkin D. M., Nguyen-Dinh X., Day N. E. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol. 1985 Feb;92(2):150–157. doi: 10.1111/j.1471-0528.1985.tb01067.x. [DOI] [PubMed] [Google Scholar]
  25. Reeves W. C., Brinton L. A., García M., Brenes M. M., Herrero R., Gaitán E., Tenorio F., de Britton R. C., Rawls W. E. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med. 1989 Jun 1;320(22):1437–1441. doi: 10.1056/NEJM198906013202201. [DOI] [PubMed] [Google Scholar]
  26. Villa L. L., Franco E. L. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst. 1989 Mar 1;81(5):332–340. doi: 10.1093/jnci/81.5.332. [DOI] [PubMed] [Google Scholar]
  27. van der Graaf Y., Zielhuis G. A., Peer P. G., Vooijs P. G. The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol. 1988;41(1):21–26. doi: 10.1016/0895-4356(88)90005-4. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES